Literature DB >> 6176678

Location and characterization of the antigenic portion of the FMDV immunizing protein.

K Strohmaier, R Franze, K H Adam.   

Abstract

Purified foot-and-mouth disease virus (FMDV) to type O1K was treated with several endopeptidases of differing specificity. The immunizing protein VPThr was cleaved into two detectable fragments by all enzymes except for glutamic acid-specific Staphylococcus aureus V8 protease. The longest fragments were generated by mouse submaxillary gland protease and the shortest by trypsin treatment of the intact virion. Several fragments, including the peptides resulting from the cyanogen bromide (CNBr) cleavage of the isolated protein VPThr were characterized in terms of their molecular weights N- and C-terminal amino acids, and ability to induce virus-specific antibodies. The order of the fragments along the protein was determined, and then located on the amino acid sequence of the protein. Two enzyme-sensitive areas of the protein were found on the surface of the virion: between sequence positions 138 and 154 and between portion 200 and the C terminus. Peptides containing these sections were able to induce neutralizing antibodies against the homologous FMDV. When the virus was treated with trypsin or with chymotrypsin, several amino acids between the detectable fragments were lost and the infectivity of the virus was reduced. The infectivity was retained, however, when the enzyme treatment resulted in cleavage of protein with no loss of amino acids or only the cutting away of the C-terminal section. These results suggest that the property of cell attachment is restricted to small regions of the surface of the virus particle.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176678     DOI: 10.1099/0022-1317-59-2-295

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  78 in total

1.  Genetical and immunological analysis of recent Asian type A and O foot-and-mouth disease virus isolates.

Authors:  B Freiberg; M M Rahman; O Marquardt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Authors:  T Jackson; A Sharma; R A Ghazaleh; W E Blakemore; F M Ellard; D L Simmons; J W Newman; D I Stuart; A M King
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.

Authors:  J N Flynn; G D Harkiss; T Doel; R DiMarchi
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

5.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay.

Authors:  Young-Joon Ko; Hyang-Sim Lee; Hye-Young Jeoung; Eun-Jeong Heo; Hyo-Rim Ko; Byung-Sik Chang; Hoo-Don Joo; U Gerelmaa; B Dashzeveg; S Tserendorj; R Sodnomdarjaa; Jong-Hyeon Park; Chang-Hee Kweon; In-Soo Cho; Sang-Gi Paik
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

7.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions.

Authors:  M A Chambers; G Dougan; J Newman; F Brown; J Crowther; A P Mould; M J Humphries; M J Francis; B Clarke; A L Brown; D Rowlands
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli.

Authors:  Joon-Goo Jung; Yong Jae Lee; Natarajan Velmurugan; Young-Joon Ko; Hyang-Sim Lee; Ki Jun Jeong
Journal:  J Ind Microbiol Biotechnol       Date:  2013-04-26       Impact factor: 3.346

10.  Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.

Authors:  M V Borca; A E Garmendia; B Baxt; D M Moore; S Srikumaran; D O Morgan
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.